111 results on '"Vigo L"'
Search Results
2. Daptomycin: a comparison of two intravenous formulations
- Author
-
Frankenfeld C, Mittal S, Melendez Y, Mendez-Vigo L, Lamp KC, Keller KN, and Bertolami SR
- Subjects
MRSA ,drug stability ,Gram-positive bacterial infections ,bacteremia ,antibiotics ,healthcare-associated infections ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Celeste Frankenfeld, Sachin Mittal, Yanira Melendez, Luke Mendez-Vigo, Kenneth C Lamp, Kaitlin N Keller, Shellie R Bertolami Merck & Co., Inc., Kenilworth, NJ, USA Abstract: Daptomycin is a cyclic lipopeptide antibacterial agent with potent bactericidal activity against a broad range of Gram-positive organisms. In 2003, daptomycin for injection received approval from the US Food and Drug Administration (FDA) for the treatment of patients with complicated skin and skin structure infections (cSSSIs); in 2006, it was approved for the treatment of patients with Staphylococcus aureus bacteremia, including those with right-sided infective endocarditis caused by methicillin-susceptible and methicillin-resistant isolates. In 2016, the FDA approved a new formulation of daptomycin for injection (daptomycin RF) for the same indications. The efficacy and safety of daptomycin for injection have been established in pivotal clinical trials, and the findings of nonclinical studies indicate that both formulations of daptomycin for injection are equivalent. Herein we refer to the new daptomycin formulation as daptomycin RF to distinguish it from the original formulation. Daptomycin RF provides clinicians and clinical pharmacists with a product that offers improved stability and more rapid, in-vial reconstitution with either sterile or bacteriostatic water for injection, while maintaining the same antibacterial coverage. Here we discuss the rationale for and the potential value of daptomycin RF, and briefly review the similarities and differences between the original formulation of daptomycin and daptomycin RF. Keywords: MRSA, drug stability, Gram-positive bacterial infections, bacteremia, antibiotics, formulation
- Published
- 2018
3. Implementación de Herramientas de Gestión de la Calidad para Reducción de Costos y Mejora de Productividad en Almacén de una Empresa Avícola. Trujillo, Perú
- Author
-
Rodríguez Alza, M. A., primary and Gomez Vigo, L. J., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Impact of acute resistance exercise on the appetite response to plant protein in young males
- Author
-
Vigo, L., primary, de Faria, L., additional, Sala, W., additional, and Horner, K., additional
- Published
- 2023
- Full Text
- View/download PDF
5. Impact of acute resistance exercise on taste perception in young, trained males
- Author
-
De Faria, L., primary, Vigo, L., additional, Sala, W., additional, and Horner, K., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study
- Author
-
Casula, M., Gazzotti, M., Bonaiti, F., Oimastroni, E., Arca, M., Averna, M., Zambon, A., Catapano, A. L., Montali, A., Giammanco, A., Biolo, G., Vinci, P., Borghi, C., D'Addato, S., Bossi, A. C., Meregalli, G., Branchi, A., Squiccimarro, G., Cavalot, F., Ramadori, L., Cipollone, F., Bucci, M., Del Ben, M., Angelico, F., Fiorenza, A. M., Colombo, E., Grigore, L., Zampoleri, V., Lupattelli, G., Gandolfo, V., Mandraffino, G., Savarino, F., Mombelli, G., Pavanello, C., Pisciotta, L., Pasta, A., Purrello, F., Scicali, R., Rubba, P., Fortunato, G., Sabba, C., Suppressa, P., Sarzani, R., Di Pentima, C., Vigna, G. B., Colangiulo, A., Werba, J. P., Vigo, L. M., Zambon, S., Previato, L., Zenti, M. G., Maneschi, C., Casula, M., Gazzotti, M., Bonaiti, F., Oimastroni, E., Arca, M., Averna, M., Zambon, A., Catapano, A. L., Montali, A., Giammanco, A., Biolo, G., Vinci, P., Borghi, C., D'Addato, S., Bossi, A. C., Meregalli, G., Branchi, A., Squiccimarro, G., Cavalot, F., Ramadori, L., Cipollone, F., Bucci, M., Del Ben, M., Angelico, F., Fiorenza, A. M., Colombo, E., Grigore, L., Zampoleri, V., Lupattelli, G., Gandolfo, V., Mandraffino, G., Savarino, F., Mombelli, G., Pavanello, C., Pisciotta, L., Pasta, A., Purrello, F., Scicali, R., Rubba, P., Fortunato, G., Sabba, C., Suppressa, P., Sarzani, R., Di Pentima, C., Vigna, G. B., Colangiulo, A., Werba, J. P., Vigo, L. M., Zambon, S., Previato, L., Zenti, M. G., Maneschi, C., Casula M, Gazzotti M, Bonaiti F, OImastroni E, Arca M, Averna M, Zambon A, Catapano AL, PROSISA Study Group, Borghi C, Casula M., Gazzotti M., Bonaiti F., OImastroni E., Arca M., Averna M., Zambon A., Catapano A.L., Montali A., Giammanco A., Biolo G., Vinci P., Borghi C., D'Addato S., Bossi A.C., Meregalli G., Branchi A., Squiccimarro G., Cavalot F., Ramadori L., Cipollone F., Bucci M., Del Ben M., Angelico F., Fiorenza A.M., Colombo E., Grigore L., Zampoleri V., Lupattelli G., Gandolfo V., Mandraffino G., Savarino F., Mombelli G., Pavanello C., Pisciotta L., Pasta A., Purrello F., Scicali R., Rubba P., Fortunato G., Sabba C., Suppressa P., Sarzani R., Di Pentima C., Vigna G.B., Colangiulo A., Werba J.P., Vigo L.M., Zambon S., Previato L., Zenti M.G., and Maneschi C.
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Settore MED/09 - Medicina Interna ,adverse effects ,myopathy ,statin-associated muscle symptoms ,statins ,030204 cardiovascular system & hematology ,Medication Adherence ,03 medical and health sciences ,0302 clinical medicine ,Muscular Diseases ,Internal medicine ,adverse effect ,Internal Medicine ,medicine ,Prevalence ,Humans ,statin‐associated muscle symptoms ,Adverse effect ,Dechallenge ,Creatine Kinase ,Dyslipidemias ,Female ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,Italy ,Middle Aged ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Odds ratio ,Original Articles ,Confidence interval ,Discontinuation ,030104 developmental biology ,Concomitant ,Cohort ,Original Article ,business ,statin-associated muscle symptom - Abstract
Aim: Statin-associated muscle symptoms (SAMS) are a major determinant of poor treatment adherence and/or discontinuation, but a definitive diagnosis of SAMS is challenging. The PROSISA study was an observational retrospective study aimed to assess the prevalence of reported SAMS in a cohort of dyslipidaemic patients. Methods: Demographic/anamnestic data, biochemical values and occurrence of SAMS were collected by 23 Italian Lipid Clinics. Adjusted logistic regression was performed to estimate odds ratio (OR) and 95% confidence intervals for association between probability of reporting SAMS and several factors. Results: Analyses were carried out on 16717 statin-treated patients (mean±SD, age 60.5±12.0years; 52.1% men). During statin therapy, 9.6% (N=1599) of patients reported SAMS. Women and physically active subjects were more likely to report SAMS (OR 1.23 [1.10–1.37] and OR 1.35 [1.14–1.60], respectively), whist age≥65 (OR 0.79 [0.70–0.89]), presence of type 2 diabetes mellitus (OR 0.62 [0.51–0.74]), use of concomitant nonstatin lipid-lowering drugs (OR 0.87 [0.76–0.99]), use of high-intensity statins (OR 0.79 [0.69–0.90]) and use of potential interacting drugs (OR 0.63 [0.48–0.84]) were associated with lower probability of reporting SAMS. Amongst patients reporting SAMS, 82.2% underwent dechallenge (treatment interruption) and/or rechallenge (change or restart of statin therapy), with reappearance of muscular symptoms in 38.4% (3.01% of the whole cohort). Conclusions: The reported prevalence of SAMS was 9.6% of the whole PROSISA cohort, but only a third of patients still reported SAMS after dechallenge/rechallenge. These results emphasize the need for a better management of SAMS to implement a more accurate diagnosis and treatment re-evaluation.
- Published
- 2020
7. Provisiones, regalos, cohechos y préstamos: la Informaçion Original de 1588 y la defensa de la autoridad virreinal en el Perú del siglo XVI
- Author
-
Costa Vigo, L. Miguel, primary
- Published
- 2021
- Full Text
- View/download PDF
8. Historia en la Pontificia Universidad Católica del Perú: el importante aporte del padre Jeffrey Klaiber S. J
- Author
-
Rosas Lauro, Claudia and Costa Vigo, L. Miguel
- Subjects
Pontificia Universidad Católica del Perú ,Jeffrey Klaiber S. J ,historia - Abstract
The objective of this article is to offer an overview of Father Klaiber’s valuable contribution to the History Speciality at the Pontificia Universidad Católica del Perú. For this purpose, documentation from the Archive of the Pontificia Universidad Católica del Perú, the Archive of the Department of Humanities of the PUCP and the Archive of the Faculty of Letters and Human Sciences of the PUCP have been used. El objetivo del artículo es ofrecer un panorama del valioso aporte del padre Klaiber a la Especialidad de Historia en la Pontificia Universidad Católica del Perú. Para ello, se ha utilizado documentación procedente del Archivo de la Pontificia Universidad Católica del Perú, el Archivo del Departamentode Humanidades de la PUCP y el Archivo de la Facultad de Letras y Ciencias Humanas de la PUCP. 
- Published
- 2020
9. Provisiones, regalos, cohechos y préstamos: la Informaçion Original de 1588 y la defensa de la autoridad virreinal en el Perú del siglo XVI
- Author
-
Costa Vigo, L. Miguel, Ediciones Universidad de Valladolid, Costa Vigo, L. Miguel, and Ediciones Universidad de Valladolid
- Abstract
Los estudios en torno a la autoridad de los virreyes en América, sus conflictos a nivel local, las acusaciones de mal gobierno y los mecanismos para controlar su desempeño han dado nuevas luces sobre la naturaleza del orden político virreinal, los alcances y límites del poder monárquico y la dinámica de constante negociación puesta. Este artículo analiza la Informaçión Original llevada a cabo en 1588 por el conde del Villar, virrey del Perú, que más allá de una auto fiscalización, fue una estrategia para recomponer su autoridad e imagen como actor político legítimo en el escenario peruano.
- Published
- 2021
10. Malnutricion e Inflamacion Subclinica en Pacientes en Hemodialisis Cronica: 0261
- Author
-
Galatte, Agustina, Linchenco, Ana Maria, Vigo, L, Feuli, Rolando, Gini, Marìa, Lotero, Alberto, Chiesa, C, Peralta, Enso, Ostera, D, and Hidalgo, R
- Published
- 2014
11. Aneurisma de aorta abdominal: a propósito de un caso
- Author
-
Gómez Vázquez, R., primary, Patiño Amboaje, I., additional, Barros Vigo, L., additional, Gesto Mouro, N., additional, Mato Baneira, M.D.C., additional, Puente González, B., additional, and Álvarez Blanco, F., additional
- Published
- 2018
- Full Text
- View/download PDF
12. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study
- Author
-
Casula, M., Olmastroni, E., Pirillo, A., Catapano, A. L., Averna, M., Bertolini, Stefania, Calandra, S., Tarugi, P., Pellegatta, F., Angelico, F., Bartuli, A., Biasucci, G., Biolo, G., Bonanni, L., Bonomo, K., Borghi, C., Bossi, A. C., Branchi, A., Carubbi, F., Cipollone, F., Citroni, N., Federici, Marco, Ferri, C., Fiorenza, A. M., Giaccari, Andrea, Giorgino, F., Guardamagna, O., Iannuzzi, A., Iughetti, L., Lupattelli, G., Lupi, Alessandro, Mandraffino, G., Marcucci, R., Maroni, L., Miccoli, R., Mombelli, Gaia, Muntoni, S., Pecchioli, V., Pederiva, C., Pipolo, A., Pisciotta, L., Pujia, A., Purrello, F., Repetti, E., Rubba, P., Sabba, C., Sampietro, T., Sarzani, R., Tagliabue, M. P., Trenti, C., Vigna, G. B., Werba, J. P., Zambon, S., Zenti, M. G., Minicocci, I., Noto, D., Fortunato, G., Banderali, G., Benso, A., Bigolin, P., Bonora, E., Bruzzi, P., Bucci, M., Buonuomo, Paola Sabrina, Capra, M. E., Cardolini, I., Cefalu, B., Cervelli, N., Chiariello, Giovanni Alfonso, Cocci, G., Colombo, E., Cremonini, A. L., D'Addato, S., D'Erasmo, L., Dal Pino, B., De Sanctis, L., De Vita, E., Del Ben, M., Di Costanzo, A., Di Taranto, M. D., Fasano, T., Gentile, L., Gentile, Marino, Ghirardello, O., Grigore, L., Lussu, M., Meregalli, G., Moffa, Simona, Montalcini, T., Morgia, V., Nascimbeni, F., Pasta, A., Pavanello, C., Saitta, A., Scicali, R., Siepi, D., Spagnolli, W., Spina, R., Sticchi, E., Suppressa, P., Vigo, L., Vinci, P., Manzato, E., Tragni, E., Zampoleri, V., Arca, M., Bertolini S., Federici M., Giaccari A. (ORCID:0000-0002-7462-7792), Lupi A., Mombelli G., Buonuomo P. S., Chiariello G., Gentile M., Moffa S., Casula, M., Olmastroni, E., Pirillo, A., Catapano, A. L., Averna, M., Bertolini, Stefania, Calandra, S., Tarugi, P., Pellegatta, F., Angelico, F., Bartuli, A., Biasucci, G., Biolo, G., Bonanni, L., Bonomo, K., Borghi, C., Bossi, A. C., Branchi, A., Carubbi, F., Cipollone, F., Citroni, N., Federici, Marco, Ferri, C., Fiorenza, A. M., Giaccari, Andrea, Giorgino, F., Guardamagna, O., Iannuzzi, A., Iughetti, L., Lupattelli, G., Lupi, Alessandro, Mandraffino, G., Marcucci, R., Maroni, L., Miccoli, R., Mombelli, Gaia, Muntoni, S., Pecchioli, V., Pederiva, C., Pipolo, A., Pisciotta, L., Pujia, A., Purrello, F., Repetti, E., Rubba, P., Sabba, C., Sampietro, T., Sarzani, R., Tagliabue, M. P., Trenti, C., Vigna, G. B., Werba, J. P., Zambon, S., Zenti, M. G., Minicocci, I., Noto, D., Fortunato, G., Banderali, G., Benso, A., Bigolin, P., Bonora, E., Bruzzi, P., Bucci, M., Buonuomo, Paola Sabrina, Capra, M. E., Cardolini, I., Cefalu, B., Cervelli, N., Chiariello, Giovanni Alfonso, Cocci, G., Colombo, E., Cremonini, A. L., D'Addato, S., D'Erasmo, L., Dal Pino, B., De Sanctis, L., De Vita, E., Del Ben, M., Di Costanzo, A., Di Taranto, M. D., Fasano, T., Gentile, L., Gentile, Marino, Ghirardello, O., Grigore, L., Lussu, M., Meregalli, G., Moffa, Simona, Montalcini, T., Morgia, V., Nascimbeni, F., Pasta, A., Pavanello, C., Saitta, A., Scicali, R., Siepi, D., Spagnolli, W., Spina, R., Sticchi, E., Suppressa, P., Vigo, L., Vinci, P., Manzato, E., Tragni, E., Zampoleri, V., Arca, M., Bertolini S., Federici M., Giaccari A. (ORCID:0000-0002-7462-7792), Lupi A., Mombelli G., Buonuomo P. S., Chiariello G., Gentile M., and Moffa S.
- Abstract
Background and aims: Familial hypercholesterolemia (FH) is an inherited disorder characterized by high levels of blood cholesterol from birth and premature coronary heart disease. Thus, the identification of FH patients is crucial to prevent or delay the onset of cardiovascular events, and the availability of a tool helping with the diagnosis in the setting of general medicine is essential to improve FH patient identification. Methods: This study evaluated the performance of the Dutch Lipid Clinic Network (DLCN) score in FH patients enrolled in the LIPIGEN study, an Italian integrated network aimed at improving the identification of patients with genetic dyslipidaemias, including FH. Results: The DLCN score was applied on a sample of 1377 adults (mean age 42.9 ± 14.2 years) with genetic diagnosis of FH, resulting in 28.5% of the sample classified as probable FH and 37.9% as classified definite FH. Among these subjects, 43.4% had at least one missing data out of 8, and about 10.0% had 4 missing data or more. When analyzed based on the type of missing data, a higher percentage of subjects with at least 1 missing data in the clinical history or physical examination was classified as possible FH (DLCN score 3–5). We also found that using real or estimated pre-treatment LDL-C levels may significantly modify the DLCN score. Conclusions: Although the DLCN score is a useful tool for physicians in the diagnosis of FH, it may be limited by the complexity to retrieve all the essential information, suggesting a crucial role of the clinical judgement in the identification of FH subjects.
- Published
- 2018
13. CENNO SUI CANTI POPOLARI STORICO-POLITICI DELLA SICILIA 1874
- Author
-
Vigo, L. and Vigo, Lionardo
- Published
- 1983
14. A systematic review of shared psychotic disorder in children and young people
- Author
-
Vigo, L., primary, Ilzarbe, D., additional, Losada, C., additional, Baeza, I., additional, and Kyriakopoulos, M., additional
- Published
- 2017
- Full Text
- View/download PDF
15. Risk awareness in ProSALUTE, a new community program for cardiovascular health in Milan, Italy
- Author
-
Werba, J.P., primary, Giroli, M., additional, Simonelli, N., additional, Vigo, L., additional, Amato, M., additional, Gorini, A., additional, Bonomi, A., additional, Veglia, F., additional, and Tremoli, E., additional
- Published
- 2017
- Full Text
- View/download PDF
16. ProSalute: A new community program for cardiovascular health
- Author
-
Werba, J.P., primary, Giroli, M., additional, Simonelli, N., additional, Vigo, L., additional, Amato, M., additional, Gorini, A., additional, Veglia, F., additional, and Tremoli, E., additional
- Published
- 2017
- Full Text
- View/download PDF
17. Investigation of barriers to and facilitators of physical activity in primary cardiovascular prevention
- Author
-
Simonelli, N., primary, Gorini, A., additional, Giroli, M., additional, Amato, M., additional, Vigo, L., additional, Tremoli, E., additional, and Werba, J.P., additional
- Published
- 2017
- Full Text
- View/download PDF
18. Early adopters of a free-access primary cardiovascular prevention program in a multiethnic community in North Italy
- Author
-
Werba, J.P., primary, Vigo, L., additional, Bonomi, A., additional, Simonelli, N., additional, Giroli, M.G., additional, Amato, M., additional, Gorini, A., additional, Veglia, F., additional, and Tremoli, E., additional
- Published
- 2017
- Full Text
- View/download PDF
19. Adherence to the Mediterranean diet in Italians and immigrants in a program for cardiovascular health
- Author
-
Giroli, M., primary, Amato, M., additional, Veglia, F., additional, Bonomi, A., additional, Vigo, L., additional, Simonelli, N., additional, Gorini, A., additional, Tremoli, E., additional, and Werba, J.P., additional
- Published
- 2017
- Full Text
- View/download PDF
20. Psychosocial factors in ProSALUTE, an ongoing cardiovascular health program in a multiethnic community in North Italy
- Author
-
Gorini, A., primary, Simonelli, N., additional, Vigo, L., additional, Giroli, M., additional, Amato, M., additional, Veglia, F., additional, Bonomi, A., additional, Tremoli, E., additional, and Werba, J.P., additional
- Published
- 2017
- Full Text
- View/download PDF
21. OC06_02 Risk Awareness in a New Community Program for Cardiovascular Health in Milan, Italy
- Author
-
Werba, J.P., primary, Giroli, M., additional, Simonelli, N., additional, Vigo, L., additional, Amato, M., additional, Gorini, A., additional, Bonomi, A., additional, Veglia, F., additional, and Tremoli, E., additional
- Published
- 2016
- Full Text
- View/download PDF
22. Hyperopia Correction Using an Erodible Mask Excimer Laser Delivery System Coupled to an Axicon: Preliminary Results
- Author
-
Rosario Brancato, Alessandro Morico, Vigo L, Pier Giorgio Gobbi, Spinelli A, Francesco Carones, and Elisabetta Venturi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Refractive error ,Adolescent ,genetic structures ,Eye disease ,medicine.medical_treatment ,Visual Acuity ,Refraction, Ocular ,Excimer ,Photorefractive Keratectomy ,Cornea ,Vision disorder ,Axicon ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,Aged ,Postoperative Care ,business.industry ,Epithelium, Corneal ,Corneal Topography ,General Medicine ,Middle Aged ,medicine.disease ,Ablation ,eye diseases ,Photorefractive keratectomy ,Surgery ,Hyperopia ,Treatment Outcome ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,Female ,Lasers, Excimer ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Purpose.This paper presents the results of the first human trial on the correction of hyperopia using an erodible mask excimer laser delivery system coupled to an axicon.Methods.We treated 17 eyes of 17 patients (age range 34–62 years) for the correction of +3.21 ± 1.04 D (range +1.00 to +4.00 D). The hyperopic correction was made using an erodible mask inserted on the laser optical pathway, to produce a circular ablation measuring 6.5 mm in diameter. An axicon was then used to create a blend transition zone from 6.5 mm up to 9.4 mm in diameter. Eyes were evaluated at one, three and six months after surgery.Results.Reepithelization was always observed by the fifth postoperative day, despite the large area of deepithelization (diameter 9.5 mm). Mean refractive error one month after treatment was −2.44 ± 1.59 D (range 0.00 to −6.50 D). Five eyes (29.4%) had a best corrected visual acuity loss more than two to three lines; all eyes showed mild annular haze not involving the central part of the cornea. Six months after treatment, mean refractive error was −0.88 ± 0.99 D (range +0.50 to −3.00 D). Compared to preoperative status, 13 eyes (76.5%) showed an improvement in uncorrected distance visual acuity (1–8 lines), and 14 eyes (82.4%) showed an improvement in uncorrected vision at reading distance (3–7 lines). Two eyes (11.7%) showed a best corrected visual acuity loss of two of three lines.Conclusions.These preliminary results indicate this approach is effective in reducing hyperopia, while its predictability has still to be proved in a larger treatment group with longer follow-up. A cautious approach to this technique is still advisable, especially for higher hyperopic corrections, in view of the large best corrected visual acuity loss seen in two eyes at six months.
- Published
- 1997
- Full Text
- View/download PDF
23. Novel RP2 mutations in European families with X-linked retinitis pigmentosa (XLRP)
- Author
-
Vigo, L, Testa, F, Miano, Mg, Conte, I, Cennamo, G, D'Urso, M, Ayuso, C, Brancato, R, Simonelli, F, Ciccodicola, A, Vigo, L, Testa, Francesco, Miano, Mg, Conte, I, Cennamo, G, D'Urso, M, Ayuso, C, Brancato, R, Simonelli, F, and Ciccodicola, A.
- Published
- 2000
24. Novel RP2 mutations in European Families with X-li nked Retinitis Pigmentosa (XLRP)
- Author
-
Vigo L, Testa F, Miano MG, Conte I, Cennamo G, D'Urso M, Ayuso C, Brancato R, Simonelli F, and Ciccodicola A
- Subjects
RP2 ,XLRP ,european patients - Published
- 2000
25. Alcohol dependence in a psychiatric interconsultation unit
- Author
-
Veiga, I., primary, Martinez, P., additional, Vigo, L., additional, Portillo, J., additional, and Gago, A., additional
- Published
- 2011
- Full Text
- View/download PDF
26. Intraperitoneal Daptomycin used to Successfully Treat Vancomycin-Resistant Enterococcus Peritonitis
- Author
-
Hassoun, A.A., primary, Coomer, R.W., additional, and Mendez-Vigo, L., additional
- Published
- 2009
- Full Text
- View/download PDF
27. Preparation and structural characterization of bis(trimethylsilylmethyl) tellurium diiodide
- Author
-
Vigo, L., primary, Salin, P., additional, Oilunkaniemi, R., additional, and Laitinen, R.S., additional
- Published
- 2006
- Full Text
- View/download PDF
28. Hyperopia Correction Using an Erodible Mask Excimer Laser Delivery System Coupled to an Axicon: Preliminary Results
- Author
-
Brancato, R., primary, Carones, F., additional, Morico, A., additional, Venturi, E., additional, Vigo, L., additional, Spinelli, A., additional, and Gobbi, P.G., additional
- Published
- 1997
- Full Text
- View/download PDF
29. The Human Corneal Endothelium after Myopic Excimer Laser Photorefractive Keratectomy. Immediate to One-Month Follow-Up
- Author
-
Carones, F., primary, Brancato, R., additional, Venturi, E., additional, and Vigo, L., additional
- Published
- 1995
- Full Text
- View/download PDF
30. P01-119 - Alcohol dependence in a psychiatric interconsultation unit
- Author
-
Veiga, I., Martinez, P., Vigo, L., Portillo, J., and Gago, A.
- Published
- 2011
- Full Text
- View/download PDF
31. Evaluation of photorefractive keratectomy retreatments after regressed myopic laser in situ keratomileusis
- Author
-
Carones, F., Vigo, L., Carones, A. V., and Brancato, R.
- Published
- 2001
- Full Text
- View/download PDF
32. Photorefractive Keratectomy for Hyperopia: Long-term Nonlinear and Vector Analysis of Refractive Outcome
- Author
-
Carones, F., Gobbi, P. G., Vigo, L., and Brancato, R.
- Published
- 1999
- Full Text
- View/download PDF
33. Laser in situ keratomileusis for hyperopia and hyperopic and mixed astigmatism with LADARVision using 7 to 10 mm ablation zones
- Author
-
Carones, F., Vigo, L., and Scandola, E.
- Published
- 2004
- Full Text
- View/download PDF
34. Tu faz In: Variedades.
- Author
-
Rocase Vigo, L.
- Published
- 1911
35. Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study
- Author
-
Castaldo, Luigi, Laguzzi, Federica, Strawbridge, Rona J., Baldassarre, Damiano, Veglia, Fabrizio, Vigo, Lorenzo, Tremoli, Elena, de Faire, Ulf, Eriksson, Per, Smit, Andries J., Aubrecht, Jiri, Leander, Karin, Pirro, Matteo, Giral, Philippe, Ritieni, Alberto, Di Minno, Giovanni, Mälarstig, Anders, Gigante, Bruna, 'Federico II' University of Naples Medical School, Karolinska Institutet [Stockholm], University of Glasgow, Centro Cardiologico Monzino [Milano], Dpt di Scienze Cliniche e di Comunità [Milano] (DISCCO), Università degli Studi di Milano [Milano] (UNIMI)-Università degli Studi di Milano [Milano] (UNIMI)-Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), University of Milan, University Medical Center Groningen [Groningen] (UMCG), Takeda Pharmaceuticals International GmbH, Perugia General Hospital, Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Groningen Kidney Center (GKC), Castaldo, L., Laguzzi, F., Strawbridge, R. J., Baldassarre, D., Veglia, F., Vigo, L., Tremoli, E., de Faire, U., Eriksson, P., Smit, A. J., Aubrecht, J., Leander, K., Pirro, M., Giral, P., Ritieni, A., Di Minno, G., Malarstig, A., and Gigante, B.
- Subjects
Male ,lcsh:QH426-470 ,carotid intima-media thickness ,Polymorphism, Single Nucleotide ,INTIMA-MEDIA THICKNESS ,Article ,TM6SF2 ,Carotid intima-media thickne ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Humans ,cardiovascular diseases ,CONFERS SUSCEPTIBILITY ,Genetic Association Studies ,POPULATION ,Aged ,RISK ,CHOLESTEROL ,non-alcoholic fatty liver disease ,Alanine Transaminase ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,Atherosclerosis ,lcsh:Genetics ,Carotid Arteries ,Amino Acid Substitution ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,CARDIOVASCULAR-DISEASE ,cardiovascular system ,CORONARY-ARTERY-DISEASE ,HEART ,Female ,alanine aminotransferase and genetic association study ,GCKR - Abstract
Non-alcoholic fatty liver disease (NAFLD) and atherosclerosis-related cardiovascular diseases (CVD) share common metabolic pathways. We explored the association between three NAFLD-associated single nucleotide polymorphisms (SNPs) rs738409, rs10401969, and rs1260326 with sub-clinical atherosclerosis estimated by the carotid intima-media thickness (c-IMT) and the inter-adventitia common carotid artery diameter (ICCAD) in patients free from clinically overt NAFLD and CVD. The study population is the IMPROVE, a multicenter European study (n = 3711). C-IMT measures and ICCAD were recorded using a standardized protocol. Linear regression with an additive genetic model was used to test for association of the three SNPs with c-IMT and ICCAD. In secondary analyses, the association of the three SNPs with c-IMT and ICCAD was tested after stratification by alanine aminotransferase levels (ALT). No associations were found between rs738409, rs1260326, rs10401969, and c-IMT or ICCAD. Rs738409-G and rs10401969-C were associated with ALT levels (p <, 0.001). In patients with ALT levels above 28 U/L (highest quartile), we observed an association between rs10401969-C and c-IMT measures of c-IMTmax and c-IMTmean-max (p = 0.018 and 0.021, respectively). In conclusion, NAFLD-associated SNPs do not associate with sub-clinical atherosclerosis measures. However, our results suggest a possible mediating function of impaired liver function on atherosclerosis development.
- Published
- 2020
- Full Text
- View/download PDF
36. Ocular Surface Workup in Patients with Meibomian Gland Dysfunction Treated with Intense Regulated Pulsed Light
- Author
-
Nicola Di Stefano, Luca Vigo, Andrea Mercanti, Leonardo Taroni, Federico Bernabei, Francesco Carones, Vincenzo Scorcia, Marco Pellegrini, Stefano Sebastiani, Giuseppe Giannaccare, and Vigo L, Taroni L, Bernabei F, Pellegrini M, Sebastiani S, Mercanti A, Di Stefano N, Scorcia V, Carones F, Giannaccare G.
- Subjects
0301 basic medicine ,medicine.medical_specialty ,intense pulsed light, meibomian gland disease, non-invasive break-up time, dry eye disease, evaporative dry eye ,medicine.medical_treatment ,Clinical Biochemistry ,Signs and symptoms ,Intense pulsed light ,meibomian gland disease ,intense pulsed light ,Article ,NO ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,evaporative dry eye ,In patient ,Osmole ,non-invasive break-up time ,lcsh:R5-920 ,business.industry ,Meibomian gland dysfunction ,Tear osmolarity ,Response to treatment ,dry eye disease ,030104 developmental biology ,030221 ophthalmology & optometry ,lcsh:Medicine (General) ,business ,Ocular surface - Abstract
The purpose of the present study was to evaluate changes of signs and symptoms in patients with meibomian gland dysfunction (MGD) treated with intense regulated pulsed light (IRPL), and to further investigate which parameter could predict positive outcomes of the procedure. Twenty-eight patients who bilaterally received three IRPL sessions at day 1, 15, and 45 satisfied the criteria and were included in the study. Non-invasive break-up time (NIBUT), lipid layer thickness (LLT), meibography, tear osmolarity, and ocular discomfort symptoms were measured before and 30 days after the last IRPL session. Qualified or complete success was defined in the presence of an improvement of symptoms associated with an increase of NIBUT (<, or &ge, 20%). After IRPL treatment, median NIBUT and LLT increased from 7.5 to 10.2 s and 2.0 to 3.0, respectively (p <, 0.001), tear osmolarity decreased from 304.0 to 301.0 mOsm/L (p = 0.002). Subjective symptoms improved after IRPL in 26 patients. Qualified success was reached in 34 eyes, while complete success in 16 eyes. Patients with lower baseline break-up time (BUT) values showed better response to treatment (p = 0.04). In conclusion, IRPL improved signs and symptoms in MGD patients, while lower baseline NIBUT values were predictive of better response to IRPL.
- Published
- 2019
37. Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
- Author
-
Luca Vigo, Marco Pellegrini, Francesco Carones, Giuseppe Giannaccare, Stefano Sebastiani, and Vigo L, Giannaccare G, Sebastiani S, Pellegrini M, Carones F.
- Subjects
Adult ,Male ,Eyelid Skin ,medicine.medical_specialty ,ocular surface disease index ,medicine.medical_treatment ,General Chemical Engineering ,Meibomian gland ,Dry eye ,intense pulsed light, MGD, dry eye ,Intense pulsed light ,intense pulsed light ,General Biochemistry, Genetics and Molecular Biology ,NO ,lipid layer thickness ,Ophthalmology ,medicine ,Humans ,Ocular Surface Disease Index ,tear osmolarity ,General Immunology and Microbiology ,business.industry ,General Neuroscience ,Intense Pulsed Light Therapy ,Meibomian gland dysfunction ,meibomian gland dysfunction ,Ablation ,Tear osmolarity ,noncontact meibography ,Dry eye, meibomian gland dysfunction, intense pulsed light, noninvasive break-up time, lipid layer thickness, noncontact meibography, tear osmolarity, ocular surface disease index ,medicine.anatomical_structure ,noninvasive break-up time ,Eyelid Diseases ,Dry Eye Syndromes ,Female ,sense organs ,business - Abstract
Dry eye disease (DED) is an increasingly common condition and one of the most common complaints of patients. The vast majority of DED is caused by the so-called "evaporative" subtype, that is mainly caused by meibomian gland dysfunction (MGD). Intense pulsed light (IPL) devices employ high intensity pulses of polychromatic lights with a broad range of wavelength (515-1200 nm). IPL treatment has been utilized for years in the field of dermatology, and then its use was applied to ophthalmology for the treatment of MGD. Recently, a new device employing IPL was specifically designed for the periocular application. This procedure determines the thermal selective coagulation and ablation of superficial blood vessels and telangiectasias of the eyelids skin, reducing the release of inflammatory mediators and tear cytokines levels, and improving meibomian glands outflow. IPL treatment is noninvasive and easy to perform, lasts for only a few minutes and can be conducted in an office setting. In the present study, 19 patients underwent 3 sessions of IPL treatment. After treatment, both mean noninvasive break-up time and lipid layer thickness grade significantly increased, as a result of an improvement of tear film stability and quality, respectively. Conversely, no statistically significant changes were found for meibomian gland loss and tear osmolarity. Furthermore, the vast majority of the treated patients (17/19; 89.5% of the total) perceived an improvement of their ocular discomfort symptoms after IPL treatment. Although IPL treatment provides an improvement of both ocular surface parameters and ocular discomfort symptoms after one cycle of three sessions, regular repeated treatments are usually required to maintain the persistence over the time of its beneficial effects.
- Published
- 2019
38. Potential use of sludge from El Ferrol Bay (Chimbote, Peru) for the production of lipids in the culture of Scenedesmus acutus (Meyen, 1829).
- Author
-
Merino F, Mendoza S, Carhuapoma-Garay J, Campoverde-Vigo L, Huamancondor-Paz YP, Choque-Quispe Y, Buleje Campos D, Choque-Quispe D, Rodriguez-Cardenas L, Saldaña-Rojas GB, Loayza-Aguilar RE, and Olivos-Ramirez GE
- Subjects
- Sewage, Lipids, Peru, Bays, Biomass, Biofuels, Scenedesmus, Microalgae
- Abstract
Despite the extensive development of microalgae biotechnology, it still requires new methodologies to lower production costs, especially in the field of biofuel production. Therefore, innovative methods that facilitate operations and enable cost-effective production are important in driving this industry. In this study, we propose a new low-cost and easy-to-use procedure, addressed to the generation of a culture medium for Scenedesmus acutus. The medium was obtained by thermal reduction of a sludge sample from El Ferrol Bay (Chimbote, Peru), whereby we obtained an aqueous medium. Our results indicated that the aqueous medium incorporates all necessary nutrients for microalgae production; allowing a maximum biomass of 0.75 ± 0.07 g/L with 60% of the medium; while high lipids production (59.42 ± 6.16%) was achieved with 20%. Besides, we quantified, in the experimental medium and at the end of the cultures, the levels of inorganic nutrients such as ammonium, nitrites, nitrates, and phosphates; in addition to COD and TOC, which were significantly reduced ( p < 0.05) after 7 days of culture, mainly in the treatment with 20%. These results suggest tremendous potential for sludge reuse, which also entails a cost reduction in microalgae biomass production, with additional positive impacts on large-scale application over highly polluted environments., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
39. Keep calm and keep rowing: the psychophysical effects of dragon boat program in breast cancer survivors.
- Author
-
Moro T, Casolo A, Bordignon V, Sampieri A, Schiavinotto G, Vigo L, Ghisi M, Paoli A, and Cerea S
- Subjects
- Female, Humans, Middle Aged, Aged, Quality of Life psychology, Ships, Hand Strength, Breast Neoplasms psychology, Cancer Survivors, Water Sports
- Abstract
Purpose: Dragon Boat discipline has become a popular type of physical exercise among women with breast cancer. The present study aims to investigate the effects of Dragon Boat activity on body composition, physical function, and psychosocial aspects (i.e., body appreciation and quality of life [QoL]) in women operated for breast cancer., Methods: Thirty-one women (age, 57.88 ± 7.88 years; BMI, 27.86 ± 6.38 kg·m
-2 ) with a previous breast removal surgery were recruited and randomized into two groups: Dragon Boat group (DB, N = 18) or a home-based non-supervised training program (home exercise group; HG, N = 13). All participants underwent body composition, handgrip test, 30-s chair stand test (30CST), 6-min walking test (6MWT), and shoulder mobility measurements at baseline and after 12 weeks of intervention. Participants also filled out the Body Appreciation Scale-2 (BAS-2) and the Short Form Health Survey-12 (SF-12) self-report questionnaires., Results: Dragon Boat activity significantly improved the 30CST (+ 6%, p = .011) and 6MWT performance (+ 30%, p = .011) compared to a home-based non-supervised training program. Moreover, 20% (3/15 women) of women in the DB group obtained a reliable change from pre- to post-intervention in the BAS-2 and in the mental QoL component of the SF-12 (vs 15% and 0% of the HC group). No reliable change emerged for the physical component of the SF-12., Conclusion: Dragon Boat activity is efficient to improve lower limb strength in women operated for breast cancer. Furthermore, Dragon Boat activity emerged to improve body appreciation and mental QoL in some of the women assigned to this activity. Importantly, no adverse events were documented during the intervention., Trial Registration: NCT05206526 (10/02/2022)., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
40. Effects of Serial Sessions of Activa Mask for the Treatment of Meibomian Gland Dysfunction.
- Author
-
Vigo L, Pellegrini M, D'Angelo S, Carones F, Scorcia V, and Giannaccare G
- Abstract
Introduction: To analyze outcomes on objective ocular surface parameters and subjective symptoms of serial weekly sessions using the Activa mask in patients with meibomian gland dysfunction (MGD)., Methods: This is a prospective study including patients with symptomatic MGD who were treated with four weekly sessions using the Activa mask (SBM Sistemi, Turin, Italy). Noninvasive ocular surface examination was carried out before (T0) and 2 weeks after the last mask session (T1) using Idra (SBM Sistemi, Turin, Italy) for the measurement of: (1) noninvasive break-up time (NIBUT); (2) lipid layer thickness (LLT); (3) tear meniscus height (TMH); (4) meibomian gland loss (MGL) of upper and lower eyelids. The I-Pen tear osmolarity system (I-Med Pharma Inc, Dollard-des Ormeaux, Quebec, Canada) was used to measure tear osmolarity values. Ocular discomfort symptoms were ascertained by means of the ocular surface disease index (OSDI) questionnaire., Results: All 25 patients (11 males, 14 females; mean age 57.1 ± 11.9 years) regularly completed the cycle of four mask sessions. No patients used prohibited medications, and no device-related adverse events were noted. At T1, mean values of NIBUT and LLT increased significantly compared to T0 (respectively from 6.0 ± 1.4 to 6.6 ± 1.2 s, P = 0.043, and from 53.2 ± 17.4 to 65.3 ± 16.3 nm, P < 0.001), while mean values of MGL and tear osmolarity decreased significantly (respectively from 17.1 ± 9.3 to 15.1 ± 8.0%, P = 0.014, and from 307.3 ± 12.2 to 301.5 ± 6.8 mOsm/l, P = 0.005). In parallel, OSDI score reduced significantly from 62.4 ± 11.7 at T0 to 34.5 ± 11.2 at T1 (P < 0.001)., Conclusion: Weekly serial sessions using the Activa mask significantly improved objective parameters of the ocular surface as well as subjective ocular discomfort symptoms in patients with recalcitrant MGD. As a further benefit from the treatment, patients were able to avoid the use of concomitant medications, apart from tear substitutes, throughout the study., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
41. Glasses-Assisted 3D Display System-Guided Descemet Membrane Endothelial Keratoplasty Tissue Preparation.
- Author
-
Borroni D, Rocha-de-Lossada C, Bonci P, Rechichi M, Rodríguez-Calvo-de-Mora M, Rachwani-Anil R, Sánchez González JM, Urbinati F, Lorente MG, Vigo L, and Carones F
- Subjects
- Cell Count, Cornea, Endothelium, Corneal transplantation, Eye Banks methods, Humans, Tissue Donors, Descemet Membrane surgery, Descemet Stripping Endothelial Keratoplasty methods
- Abstract
Purpose: The aim of this study was to evaluate the feasibility of Descemet membrane endothelial keratoplasty (DMEK) tissue preparation using a glasses-assisted 3-dimensional (3D) display system and to compare it with a conventional surgical microscope., Methods: Healthy pairs of human corneas suitable for penetrating keratoplasty surgery were selected for this study. The tissues were randomly divided into 2 groups. Each pair of corneas had 1 cornea (group 1) prepared with NGENUITY (Alcon) with a 5-second staining time with vision blue, and the fellow cornea (group 2) was prepared using a OPMI Lumera 700 surgical microscope (Carl Zeiss Meditec, Jena, Germany) with a 30-second staining time. DMEK graft preparation time, speed of stripping, graft width, and endothelial cell loss were evaluated., Results: Twenty-eight pairs of corneas were included in this study. The graft preparation time was significantly higher in the 3D group than in the conventional group (498 ± 147 vs. 418 ± 85 seconds, P value = 0.031). The mean speed of stripping was 0.59 ± 0.081 mm/s in group 1 and 0.089 ± 0.005 mm/s in group 2 ( P value = 0.024). The mean endothelial cell density in group 1 and group 2 before tissue preparation was 2162 ± 115.21 and 2153 ± 122.45, respectively ( P value > 0.1). After tissue preparation, the endothelial cell density reduced to 1911 ± 150.72 in group 1 and 1998 ± 90.72 in group 2 ( P value = P value > 0.05). The graft width was 5.05 ± 0.71 mm in group 1 and 4.92 ± 0.23 mm in group 2 ( P value > 0.05)., Conclusions: DMEK tissue preparation with 3D display system NGENUITY is feasible with a slightly increased preparation time. The improved visualization allows a reduced staining time that could be beneficial for eye banks because it may reduce the toxic effect of staining colorants., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
42. Effects of a New Formulation of Multiple-Action Tear Substitute on Objective Ocular Surface Parameters and Ocular Discomfort Symptoms in Patients with Dry Eye Disease.
- Author
-
Vigo L, Senni C, Pellegrini M, Vagge A, Ferro Desideri L, Carones F, Scorcia V, and Giannaccare G
- Abstract
Introduction: Recently, there has been a progressive shift from simple water-adding medications towards complex multi-action combined formulas aimed at disrupting different mechanisms within the dry eye disease (DED) vicious cycle. This study evaluated the efficacy and tolerability of Trimix eye drops (Off Health Italia, Italy), a combination of viscosity-enhancing hyaluronic acid, trehalose, and cationic liposomes comprising stearylamine and phospholipids, in patients with DED., Methods: In this prospective, pilot study patients diagnosed with mild to moderate DED were enrolled and treated with Trimix eye drops three times daily for 2 months. Ocular surface workup was performed before (V0) and after therapy (V1) by means of IDRA (SBM Sistemi, Turin, Italy), for the measurement of (i) noninvasive break-up time (NIBUT); (ii) tear meniscus height (TMH); (iii) lipid layer thickness (LLT); (iv) infrared meibography (percentage of meibomian gland loss); (v) bulbar redness (Efron scale). Treatment tolerability was scored on a visual analog scale ranging from 0 (none/not at all) to 100 (much/very) for eight questions. Ocular discomfort symptoms were scored using the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire., Results: Overall, 25 subjects (mean age 60.32 ± 14.55 years) were included in the study. At V1, TMH, NIBUT, and LLT significantly increased compared to V0 (from 0.29 ± 0.06 to 0.46 ± 0.06 mm, 6.34 ± 2.61 to 7.58 ± 2.52 s, and from 63.26 ± 17.15 to 68.42 ± 15.63 nm, respectively; all P < 0.04). Concerning ocular discomfort symptoms, SPEED score significantly improved at V1 (from 16.63 ± 6.32 to 8.30 ± 5.98; P < 0.001); moreover, treatment tolerability was high for all eight items investigated., Conclusions: Two-month treatment with Trimix formulation improved objective signs and subjective symptoms in patients with DED, showing also a good tolerability profile., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
43. Outcomes of serial sessions of Activa mask combined with intense pulsed light therapy in patients with Meibomian gland dysfunction.
- Author
-
Vigo L, Pellegrini M, Carones F, Scorcia V, and Giannaccare G
- Subjects
- Humans, Meibomian Glands, Tears, Dry Eye Syndromes diagnosis, Dry Eye Syndromes therapy, Intense Pulsed Light Therapy, Meibomian Gland Dysfunction therapy
- Abstract
Background: To evaluate the effects on ocular surface signs and symptoms of serial sessions of heating and vibrating eye mask followed by intense pulsed light (IPL) therapy for the treatment of dry eye disease owing to meibomian gland dysfunction (MGD)., Methods: Consecutive patients with MGD whose signs and symptoms were not satisfactorily controlled with conventional therapy were included. Patients received 3 treatments performed at day 1, 15, and 45 incorporating a session with a newly-developed eye mask (Activa, SBS Sistemi, Turin, Italy) immediately followed by IPL therapy (E > Eye device, E-Swin, Paris, France). Patients were examined before the first session (T0) and 30 days after the last session (T1) for the measurement of: noninvasive break-up time (NIBUT); lipid layer thickness (LLT); tear meniscus height (TMH); meibomian gland loss (MGL); tear osmolarity. Ocular discomfort symptoms were ascertained by ocular surface disease index (OSDI) questionnaire., Results: Thirty patients were ultimately included in the study. At T1, all objective ocular surface parameters improved significantly, except for TMH: NIBUT and LLT increased from 6.4 ± 1.7 to 8.6 ± 1.7 s and from 57.7 ± 15.5 to 81.3 ± 12.0 μm (all P < 0.001), while MGL and tear osmolarity decreased from 21.1 ± 17.3 to 17.0 ± 14.1% and from 302.0 ± 8.5 to 295.7 ± 6.9 mOsm/L (respectively, P = 0.004 and P < 0.001). In parallel, OSDI score decreased significantly from 49.8 ± 13.5 to 29.8 ± 10.6 (P < 0.001). In the historical control group of patients who underwent only IPL, NIBUT, LLT, tear osmolarity and OSDI improved significantly but not MGL and TMH., Conclusions: Serial sessions incorporating the application of an eye mask producing heating and vibration immediately followed by IPL therapy are able to improve all ocular surface parameters as well as ocular discomfort symptoms in MGD patients., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery.
- Author
-
Werba JP, Bonomi A, Giroli M, Amato M, Vigo L, Agrifoglio M, Alamanni F, Cavallotti L, Kassem S, Naliato M, Parolari A, Penza E, Polvani G, Pompilio G, Porqueddu M, Roberto M, Salis S, Zanobini M, Amato M, Baldassarre D, Veglia F, and Tremoli E
- Subjects
- Case-Control Studies, Coronary Artery Bypass adverse effects, Female, Humans, Male, Recurrence, Retrospective Studies, Secondary Prevention, Treatment Outcome, Cardiovascular Diseases etiology, Coronary Artery Disease etiology, Coronary Artery Disease surgery
- Abstract
Aims: Patients with coronary heart disease (CHD) are at very high risk of recurrent events. A strategy to reduce excess risk might be to deliver structured secondary prevention programmes, but their efficacy has been mostly evaluated in the short term and in experimental settings. This is a retrospective case-control study aimed at assessing, in the real world, the efficacy of a secondary prevention programme in reducing long-term coronary event recurrences after coronary artery bypass surgery (CABG)., Methods and Results: Programme participants (henceforth 'cases') were men and women aged <75 years subjected to CABG between 2002 and 2014, living within 100 km of the hospital. Key programme actions included optimization of treatments according to the most updated European preventive guidelines, surveillance of therapy adherence, and customized lifestyle counselling. Controls were analogous patients not involved in the programme because living farther than 100 km away, matched 1:1 with cases for gender, age at CABG, and year of CABG. Both groups (n = 1248) underwent usual periodic cardiology follow-up at our centre. Data on symptomatic or silent CHD recurrences were obtained from the hospital electronic health records. Cox analysis (adjusted for baseline differences between groups) shows that programme participation was associated with a significantly lower incidence throughout 5 years post-CABG of symptomatic [hazard ratio (95% confidence interval): 0.59 (0.38-0.94)] and silent [0.53 (0.31-0.89)] coronary recurrences., Conclusion: In a real-world setting, taking part in a structured longstanding secondary prevention programme, in addition to usual cardiology care, meaningfully lowers the risk of coronary recurrences., (© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2022
- Full Text
- View/download PDF
45. Uptake and effectiveness of a primary cardiovascular prevention program in an underserved multiethnic urban community.
- Author
-
Werba JP, Giroli MG, Simonelli N, Vigo L, Gorini A, Bonomi A, Veglia F, and Tremoli E
- Subjects
- Adult, Aged, Blood Glucose, Blood Pressure, Diet, Female, Humans, Male, Middle Aged, Primary Prevention, Cardiovascular Diseases diagnosis, Cardiovascular Diseases epidemiology, Cardiovascular Diseases prevention & control, Exercise
- Abstract
Background and Aims: Cardiometabolic risk is increased among disadvantaged people and ethnic minorities. Paradoxically, their uptake of primary cardiovascular prevention is relatively low. New strategies are needed to tackle this public health problem. Aims of this study were to assess the uptake (as well as its determinants) and effectiveness of a primary cardiovascular prevention program for communities devised to facilitate access of disadvantaged and inclusion of ethnic minorities in addition to providing a state-of-the-art interdisciplinary personalized care., Methods and Results: Single center, hospital-based, open study. All the residents in an underserved multiethnic urban community aged 40-65 years (n = 1646, 43.6% immigrants) were proactively invited by post mail to participate in a cardiovascular prevention program and different approaches were adopted to promote accessibility and inclusiveness. Program uptake was 23% and individual features independently associated with program uptake were status of immigrant (OR [CI 95%]: 3.6 [2.6-5.1]), higher educational level (3.6 [2.8-4.7]), and female gender (1.6 [1.2-2.1]). Retention was 82% at 6 months and 69% at 12 months. A predefined outcome of global cardiovascular risk improvement at 12 months in subjects with glycaemia >126 mg/dl, LDL-C >115 mg/dl, systolic blood pressure ≥140 mmHg or BMI >28 at baseline was reached in 35%, 33%, 37% and 7% of the patients, respectively. 20% of smokers quitted and significant favorable changes were reported in diet quality, anxiety, depression and physical activity., Conclusion: Access inequalities to effective prevention may be counteracted, but increasing global uptake requires further upstream sensitization and awareness actions. REGISTERED IN CLINICALTRIALS.GOV: NCT03129165., Competing Interests: Declaration of competing interest Nothing to disclose., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
46. Surgical Antimicrobial Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Eye Surgery: A RAND/UCLA Appropriateness Method Consensus Study.
- Author
-
Bianchini S, Morini C, Nicoletti L, Monaco S, Rigotti E, Caminiti C, Conti G, De Luca M, Donà D, Maglietta G, Lancella L, Lo Vecchio A, Marchini G, Pietrasanta C, Principi N, Simonini A, Venturini E, Longo R, Gusson E, Boccuzzi D, Vigo L, Mosca F, Staiano A, Esposito S, and On Behalf Of The Peri-Operative Prophylaxis In Neonatal And Paediatric Age Pop-NeoPed Study Group
- Abstract
Ocular surgery encompasses a wide range of procedures, including surgery of the tear ducts, eyelid, cornea and conjunctiva, lens, ocular muscle, and vitreoretinal and iris surgery. Operations are also performed for the removal of tumors, repairs of ocular trauma and, finally, corneal transplantation. Antibiotic prophylaxis for the prevention of surgical site infections (SSIs) in ocular surgery is a complex field in which shared lines of action are absent. In light of the scarcity of shared evidence in the use of ocular antimicrobial prophylaxis for the pediatric population, this consensus document aims to provide clinicians with a series of recommendations on antimicrobial prophylaxis for patients of neonatal and pediatric age undergoing eye surgery. The following scenarios are considered: (1) intraocular surgery; (2) extraocular surgery; (3) ocular trauma; (4) ocular neoplasm; (5) ocular surface transplantations; (6) corneal grafts. This work has been made possible by the multidisciplinary contribution of experts belonging to the most important Italian scientific societies and represents, in our opinion, the most complete and up-to-date collection of recommendations regarding clinical actions in the peri-operative environment in eye surgery. The application of uniform and shared protocols aims to improve surgical practice, through the standardization of procedures, with a consequent reduction of SSIs, also limiting the phenomenon of antimicrobial resistance.
- Published
- 2022
- Full Text
- View/download PDF
47. Short-Term Effects of a Novel Eye Mask Producing Heat and Vibration for the Treatment of Meibomian Gland Dysfunction: A Pilot Study.
- Author
-
Vigo L, Pellegrini M, Carones F, Scorcia V, and Giannaccare G
- Abstract
Purpose: To investigate the short-term effects on tear film parameters and ocular symptoms of a novel eye mask producing heat and vibration developed for the treatment of dry eye disease owing to meibomian gland dysfunction (MGD)., Methods: This is a pilot study including the first 20 consecutive patients (6 males, 14 females; mean age 52.4 ± 16.8 years) who were treated with a novel eye mask producing heat (42°) and vibration (up to 20 Hz) (Activa, SBS Sistemi, Turin, Italy) for 15 minutes. The treatment incorporates 2 phases in the following chronological order: 5 minutes of heating (phase I); 10 minutes of combination of heating and vibration (phase II). Noninvasive ocular surface examination was carried out before (T0) and 30 minutes after the mask session (T1) by means of Idra (SBS Sistemi, Turin, Italy) for the measurement of noninvasive break-up time (NIBUT) and lipid layer thickness (LLT). Patients' satisfaction after treatment was ascertained by asking the patients whether they perceived improvement from their baseline symptoms according to a 5-grade scale: none = 0; trace = 1; mild = 2; moderate = 3; high = 4., Results: All patients completed regularly the mask session and no device-related adverse events were noted. NIBUT improved significantly from T0 to T1 (from 7.2 ± 1.8 s to 8.1 ± 2.1; P = 0.014). In parallel, also LLT improved from from T0 to T1 (72.5 ± 13.9 nm to 83.1 ± 16.1; P = 0.016). Seven patients (35% of the total) had a moderate satisfaction (grade 3) while 13 patients (65%) had a high satisfaction (grade 4) with treatment., Conclusions: This eye mask represents a novel well tolerated tool in the armamentarium of MGD treatments. Thirty minutes after the session, NIBUT and LLT increased significantly; furthermore, all patients reported an improvement of discomfort symptoms with a moderate to high satisfaction with treatment., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2021 Luca Vigo et al.)
- Published
- 2021
- Full Text
- View/download PDF
48. Diagnostic Performance of a Novel Noninvasive Workup in the Setting of Dry Eye Disease.
- Author
-
Vigo L, Pellegrini M, Bernabei F, Carones F, Scorcia V, and Giannaccare G
- Abstract
Purpose: To evaluate the diagnostic performance of a novel noninvasive automated workup employed for the diagnosis of dry eye disease (DED)., Methods: One hundred patients with mild to moderate DED and 100 matched control subjects were enrolled in this cross-sectional study. Ocular surface examinations were carried out by means of IDRA Plus (SBM Sistemi, Turin, Italy), which allows the automated evaluation of noninvasive breakup time (NIBUT), lipid layer thickness (LLT), tear meniscus height (TMH), infrared meibography for the measurement of meibomian gland loss (MGL), and blinking analysis. Continuous variables were compared between patients with DED and controls by using the Mann-Whitney U test. The area under the curve (AUC) of receiver operating characteristic curves was calculated. The correlations between ocular surface parameters were evaluated with Pearson correlation analysis., Results: Patients with DED showed significantly lower values of NIBUT, LLT, and TMH compared to controls (6.9 ± 2.5 vs 10.4 ± 2.4 s, P < 0.001; 64.6 ± 20.3 vs 73.4 ± 21.9 nm, P = 0.003; 0.231 ± 0.115 vs 0.289 ± 0.164, P = 0.012, respectively). Conversely, no significant differences were observed for MGL and blinking analysis (both P > 0.05). NIBUT had the highest diagnostic power (AUC = 0.841, sensitivity = 0.89, and specificity = 0.69), followed by LLT (AUC = 0.621, sensitivity = 0.89, and specificity = 0.55), TMH (AUC = 0.606, sensitivity = 0.57, and specificity = 0.63), blink analysis (AUC = 0.533, sensitivity = 0.48, and specificity = 0.59), and MGL (AUC = 0.531, sensitivity = 0.54, and specificity = 0.48). In patients with DED, NIBUT showed a significant correlation with TMH ( R = 0.347, P = 0.002) and blinking analysis ( R = 0.356, P < 0.001), while blinking analysis was negatively correlated with MGL ( R = -0.315, P = 0.008)., Conclusions: The automated noninvasive workup validated in this study may be a useful tool for reaching a noninvasive diagnosis of DED with a good performance, especially for NIBUT., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2020 Luca Vigo et al.)
- Published
- 2020
- Full Text
- View/download PDF
49. Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study.
- Author
-
Castaldo L, Laguzzi F, Strawbridge RJ, Baldassarre D, Veglia F, Vigo L, Tremoli E, de Faire U, Eriksson P, Smit AJ, Aubrecht J, Leander K, Pirro M, Giral P, Ritieni A, Di Minno G, Mälarstig A, and Gigante B
- Subjects
- Aged, Alanine Transaminase blood, Amino Acid Substitution genetics, Carotid Intima-Media Thickness, Female, Genetic Association Studies, Humans, Male, Atherosclerosis genetics, Carotid Arteries physiology, Non-alcoholic Fatty Liver Disease genetics, Polymorphism, Single Nucleotide genetics
- Abstract
Non-alcoholic fatty liver disease (NAFLD) and atherosclerosis-related cardiovascular diseases (CVD) share common metabolic pathways. We explored the association between three NAFLD-associated single nucleotide polymorphisms (SNPs) rs738409, rs10401969, and rs1260326 with sub-clinical atherosclerosis estimated by the carotid intima-media thickness (c-IMT) and the inter-adventitia common carotid artery diameter (ICCAD) in patients free from clinically overt NAFLD and CVD. The study population is the IMPROVE, a multicenter European study ( n = 3711). C-IMT measures and ICCAD were recorded using a standardized protocol. Linear regression with an additive genetic model was used to test for association of the three SNPs with c-IMT and ICCAD. In secondary analyses, the association of the three SNPs with c-IMT and ICCAD was tested after stratification by alanine aminotransferase levels (ALT). No associations were found between rs738409, rs1260326, rs10401969, and c-IMT or ICCAD. Rs738409-G and rs10401969-C were associated with ALT levels ( p < 0.001). In patients with ALT levels above 28 U/L (highest quartile), we observed an association between rs10401969-C and c-IMT measures of c-IMT
max and c-IMTmean-max ( p = 0.018 and 0.021, respectively). In conclusion, NAFLD-associated SNPs do not associate with sub-clinical atherosclerosis measures. However, our results suggest a possible mediating function of impaired liver function on atherosclerosis development.- Published
- 2020
- Full Text
- View/download PDF
50. Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials.
- Author
-
Frigerio B, Werba JP, Amato M, Ravani A, Sansaro D, Coggi D, Vigo L, Tremoli E, and Baldassarre D
- Subjects
- Binge Drinking complications, Cohort Studies, Diabetes Mellitus, Humans, Hypercholesterolemia complications, Hypertension complications, Obesity complications, Observational Studies as Topic, Risk Factors, Smoking, Ultrasonography, Carotid Intima-Media Thickness, Disease Progression
- Abstract
In the present review, associations between traditional vascular risk factors (VRFs) and carotid intimamedial thickness progression (C-IMTp) as well as the effects of therapies for VRFs control on C-IMTp were appraised to infer causality between each VRF and C-IMTp. Cohort studies indicate that smoking, binge drinking, fatness, diabetes, hypertension and hypercholesterolemia are associated with accelerated C-IMTp. An exception is physical activity, with mixed data. Interventions for the control of obesity, diabetes, hypertension and hypercholesterolemia decelerate C-IMTp. Conversely, scarce information is available regarding the effect of smoking cessation, stop of excessive alcohol intake and management of the metabolic syndrome. Altogether, these data support a causative role of several traditional VRFs on C-IMTp. Shortcomings in study design and/or ultrasonographic protocols may account for most negative studies, which underlines the importance of careful consideration of methodological aspects in investigations using C-IMTp as the outcome., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.